Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H H Parving

Showing results (271-280 of 306) with videos related to

Pageof 31
Sort By:
Clinical Science (London, England : 1979)|October 1, 1986
Effect of ganglionic blockade on endogenous circulating pancreatic polypeptide, vasoactive intestinal polypeptide, substance P, neurotensin and noradrenaline in healthy controls and long-term insulin-dependent diabetic patientsJ Kastrup, J H Henriksen, J H Pedersen, et al.
Applied Pathology|January 1, 1984
Quantitative studies of glomerular ultrastructure in human and experimental diabetesR Osterby, I B Brekke, H J Gundersen, et al.
Diabetologia|December 1, 1996
Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathyH H Parving, F S Nielsen, L E Bang, et al.
Cardiovascular Diabetology|April 28, 2017
Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up studyS A Peeters, L Engelen, J Buijs, et al.
Acta Medica Scandinavica|January 1, 1986
Prevalence of hyperglycaemia and undiagnosed diabetes mellitus in patients with acute myocardial infarctionJ K Madsen, S Haunsøe, S Helquist, et al.
Diabetes, Obesity & Metabolism|March 30, 2007
Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trialS S Lund, L Tarnow, C D A Stehouwer, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 1, 1997
Left ventricular hypertrophy in non-insulin-dependent diabetic patients with and without diabetic nephropathyF S Nielsen, S Ali, P Rossing, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 13, 1999
Increased sympathetic activity during sleep and nocturnal hypertension in Type 2 diabetic patients with diabetic nephropathyF S Nielsen, H P Hansen, P Jacobsen, et al.
Diabetologia|October 1, 2010
Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trialY Miao, D Dobre, H J Lambers Heerspink, et al.
Kidney International|March 14, 2008
Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetesF Persson, P Rossing, K J Schjoedt, et al.
Pageof 31

Showing results (271-280 of 306) with videos related to

Sort By:
Pageof 31
Clinical Science (London, England : 1979)|October 1, 1986
Effect of ganglionic blockade on endogenous circulating pancreatic polypeptide, vasoactive intestinal polypeptide, substance P, neurotensin and noradrenaline in healthy controls and long-term insulin-dependent diabetic patientsJ Kastrup, J H Henriksen, J H Pedersen, et al.
Applied Pathology|January 1, 1984
Quantitative studies of glomerular ultrastructure in human and experimental diabetesR Osterby, I B Brekke, H J Gundersen, et al.
Diabetologia|December 1, 1996
Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathyH H Parving, F S Nielsen, L E Bang, et al.
Cardiovascular Diabetology|April 28, 2017
Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up studyS A Peeters, L Engelen, J Buijs, et al.
Acta Medica Scandinavica|January 1, 1986
Prevalence of hyperglycaemia and undiagnosed diabetes mellitus in patients with acute myocardial infarctionJ K Madsen, S Haunsøe, S Helquist, et al.
Diabetes, Obesity & Metabolism|March 30, 2007
Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trialS S Lund, L Tarnow, C D A Stehouwer, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 1, 1997
Left ventricular hypertrophy in non-insulin-dependent diabetic patients with and without diabetic nephropathyF S Nielsen, S Ali, P Rossing, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 13, 1999
Increased sympathetic activity during sleep and nocturnal hypertension in Type 2 diabetic patients with diabetic nephropathyF S Nielsen, H P Hansen, P Jacobsen, et al.
Diabetologia|October 1, 2010
Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trialY Miao, D Dobre, H J Lambers Heerspink, et al.
Kidney International|March 14, 2008
Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetesF Persson, P Rossing, K J Schjoedt, et al.
Pageof 31